Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Huber

Showing results (1-10 of 752) with videos related to

Pageof 76
Sort By:
European Heart Journal|September 18, 2010
Genetic variability in response to clopidogrel therapy: clinical implicationsKurt Huber
JACC. Cardiovascular Interventions|October 24, 2015
Prasugrel in Clopidogrel Nonresponders: A Way to Improve Secondary Prevention in Patients After Percutaneous Coronary Intervention?Kurt Huber
JACC. Cardiovascular Interventions|May 12, 2018
Current Definitions of Non-ST-Segment Elevation Myocardial Infarction: Challenges for Further ImprovementKurt Huber
Advances in Cardiology|August 22, 2012
Clopidogrel in coronary artery disease: update 2012Kurt Huber
Circulation. Cardiovascular Interventions|June 6, 2018
Is Treatment of ST-Segment-Elevation Myocardial Infarction Patients With Ticagrelor or Other P2Y<sub>12</sub> Inhibitors Before Primary Percutaneous Coronary Intervention a Strategy Without Benefit?Kurt Huber
European Heart Journal|October 6, 2020
The Association for Acute Cardiovascular CareKurt Huber
Journal of Thrombosis and Thrombolysis|November 18, 2003
The role of glycoprotein IIb/IIIa-receptor antagonists in diabeticsKurt Huber
Circulation|November 8, 2007
European Society of Cardiology Working Groups. Working Group 18: Thrombosis. Interview by Emma WilkinsonKurt Huber
European Heart Journal|November 29, 2011
Optimizing reperfusion therapy in acute ST-elevation myocardial infarction by a pharmaco-invasive treatment approach in a well-organized networkKurt Huber
European Heart Journal|June 10, 2021
Scores for outcome prediction in patients admitted with cardiogenic shockKurt Huber
Pageof 76

Showing results (1-10 of 752) with videos related to

Sort By:
Pageof 76
European Heart Journal|September 18, 2010
Genetic variability in response to clopidogrel therapy: clinical implicationsKurt Huber
JACC. Cardiovascular Interventions|October 24, 2015
Prasugrel in Clopidogrel Nonresponders: A Way to Improve Secondary Prevention in Patients After Percutaneous Coronary Intervention?Kurt Huber
JACC. Cardiovascular Interventions|May 12, 2018
Current Definitions of Non-ST-Segment Elevation Myocardial Infarction: Challenges for Further ImprovementKurt Huber
Advances in Cardiology|August 22, 2012
Clopidogrel in coronary artery disease: update 2012Kurt Huber
Circulation. Cardiovascular Interventions|June 6, 2018
Is Treatment of ST-Segment-Elevation Myocardial Infarction Patients With Ticagrelor or Other P2Y<sub>12</sub> Inhibitors Before Primary Percutaneous Coronary Intervention a Strategy Without Benefit?Kurt Huber
European Heart Journal|October 6, 2020
The Association for Acute Cardiovascular CareKurt Huber
Journal of Thrombosis and Thrombolysis|November 18, 2003
The role of glycoprotein IIb/IIIa-receptor antagonists in diabeticsKurt Huber
Circulation|November 8, 2007
European Society of Cardiology Working Groups. Working Group 18: Thrombosis. Interview by Emma WilkinsonKurt Huber
European Heart Journal|November 29, 2011
Optimizing reperfusion therapy in acute ST-elevation myocardial infarction by a pharmaco-invasive treatment approach in a well-organized networkKurt Huber
European Heart Journal|June 10, 2021
Scores for outcome prediction in patients admitted with cardiogenic shockKurt Huber
Pageof 76